ARTICLE | Company News
Avigen licenses to Stratagene
July 11, 2000 7:00 AM UTC
Stratagene (La Jolla, Calif.) obtained worldwide exclusive rights from AVGN to sell kits for making recombinant adeno-associated virus (AAV) vectors. AVGN will receive an upfront payment, royalties on...